0002139106-26-000001.txt : 20260609 0002139106-26-000001.hdr.sgml : 20260609 20260609130138 ACCESSION NUMBER: 0002139106-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20260609 DATE AS OF CHANGE: 20260609 EFFECTIVENESS DATE: 20260609 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Verdad Biotech Fund, L.P. CENTRAL INDEX KEY: 0002139106 ORGANIZATION NAME: EIN: 414473926 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-586685 FILM NUMBER: 261075349 BUSINESS ADDRESS: STREET 1: 695 ATLANTIC AVE. STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02111 BUSINESS PHONE: 202-251-6707 MAIL ADDRESS: STREET 1: 695 ATLANTIC AVE. STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02111 D 1 primary_doc.xml X0708 D LIVE 0002139106 Verdad Biotech Fund, L.P. 695 ATLANTIC AVE. 4TH FLOOR BOSTON MA MASSACHUSETTS 02111 202-251-6707 DELAWARE None None Limited Partnership true 2026 N/A VCLF GP, L.P. 695 ATLANTIC AVE. 4TH FLOOR BOSTON MA MASSACHUSETTS 02111 Executive Officer General Partner Dan Rasmussen 695 ATLANTIC AVE. 4th FLOOR BOSTON MA MASSACHUSETTS 02111 Executive Officer Manager of Verdad Asset Management, LLC N/A Verdad Asset Management 695 ATLANTIC AVE. 4th FLOOR BOSTON MA MASSACHUSETTS 02111 Executive Officer General Partner of VLCF GP, L.P., General Partner Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 false 2026-04-01 true true false 0 Indefinite 8099001 Indefinite false 9 0 0 None, although the general partner of the issuer receives investment management fees and a special profit allocation. 0 false Verdad Biotech Fund, L.P. /s/ Dan Rasmussen Dan Rasmussen Chief Compliance Officer 2026-06-09